Shilpa Medicare Limited
NSE: SHILPAMED BSE: SHILPAMED
NSE
658.10
-10.40 (-1.56%)
Prev Close
668.5
Open Price
671.2
Volume
163,074
Today Low / High
655.05 / 677.4
52 WK Low / High
417.6 / 959.5
Range
625 - 691
BSE
658.65
-13.15 (-1.96%)
Prev Close
671.8
Open Price
679.95
Volume
9,624
Today Low / High
655 / 679.95
52 WK Low / High
419.1 / 959.95
Range
626 - 692
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 658.1 (target range: 625 - 691), reflecting a change of -10.4 (-1.55572%). On the BSE, it is listed at 658.65 (target range: 626 - 692), showing a change of -13.15 (-1.95743%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
21 Apr
671.20
-1.95%
17 Apr
661.55
1.05%
16 Apr
659.85
0.26%
15 Apr
643.95
1.82%
11 Apr
638.00
0.30%
09 Apr
630.00
-3.16%
08 Apr
624.40
2.91%
07 Apr
555.00
9.85%
04 Apr
666.50
-5.54%
03 Apr
660.00
2.54%
02 Apr
654.00
-0.90%
01 Apr
660.00
-0.41%
28 Mar
685.10
-3.17%
27 Mar
665.90
2.67%
26 Mar
675.00
-0.68%
25 Mar
700.00
-3.70%
24 Mar
690.00
0.87%
Shilpa Medicare Limited Graph
Shilpa Medicare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Shilpa Medicare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 658.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 658.65 | 665.24 | 598.71 - 731.76 |
| 671.82 | 537.46 - 806.19 | ||
| 678.41 | 474.89 - 881.93 | ||
| Bearish Scenario | 658.65 | 652.06 | 586.86 - 717.27 |
| 645.48 | 516.38 - 774.57 | ||
| 638.89 | 447.22 - 830.56 |
Overview of Shilpa Medicare Limited
ISIN
INE790G01031
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
285,202
Market Cap
64,356,197,871
Last Dividend
0
Official Website
IPO Date
2009-12-03
DCF Diff
1,270.90
DCF
-595
Financial Ratios Every Investor Needs
Stock Dividend of SHILPAMED
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2022-09-19 | September 19, 22 | 1.1 | 1.1 | 2022-09-20 | 2022-10-28 | |
| 2021-09-17 | September 17, 21 | 1.1 | 1.1 | 2021-09-21 | 2021-10-28 | |
| 2020-03-16 | March 16, 20 | 1.1 | 1.1 | 2020-03-17 | 2020-04-05 | 2020-03-03 |
| 2019-09-12 | September 12, 19 | 1 | 1 | 2019-09-13 | 2019-10-20 | 2019-05-27 |
| 2018-03-01 | March 01, 18 | 0.7 | 0.7 | 2018-03-05 | 2018-03-24 | 2018-02-19 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1,153.11 Cr | 443.53 Cr | 709.57 Cr | 0.6154 | 30.96 Cr | 299.59 Cr | 376.16 Cr | 31.87 Cr | 3.67 | 245.94 Cr | 0.0276 |
| 2023-03-31 | 1,043.45 Cr | 416.84 Cr | 626.60 Cr | 0.6005 | 49.10 Cr | 29.53 Cr | -4.60 Cr | -32.53 Cr | -3.75 | 113.47 Cr | -0.0312 |
| 2022-03-31 | 1,140.05 Cr | 384.10 Cr | 755.95 Cr | 0.6631 | 55.06 Cr | 57.74 Cr | 125.83 Cr | 60.66 Cr | 7.26 | 226.89 Cr | 0.0532 |
| 2021-03-31 | 900.16 Cr | 270.77 Cr | 629.39 Cr | 0.6992 | 33.81 Cr | 35.72 Cr | 119.30 Cr | 147.78 Cr | 18.13 | 272.63 Cr | 0.1642 |
| 2020-03-31 | 898.88 Cr | 277.73 Cr | 621.14 Cr | 0.6910 | 36.90 Cr | 54.18 Cr | 172.64 Cr | 156.15 Cr | 19.15 | 236.74 Cr | 0.1737 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 30.23 Cr | 3,093.20 Cr | 1,293.25 Cr | 1,808.6941 Cr | 937.39 Cr | 907.16 Cr | 344.93 Cr | 1,638.50 Cr | 0.01 Cr | 0.00 Cr | 39.91 Cr | 693.3482 Cr |
| 2023-03-31 | 21.32 Cr | 2,903.93 Cr | 1,129.57 Cr | 1,783.2770 Cr | 797.89 Cr | 776.57 Cr | 319.82 Cr | 1,537.49 Cr | 0.00 Cr | 17.48 Cr | 53.56 Cr | 784.4477 Cr |
| 2022-03-31 | 33.83 Cr | 2,875.50 Cr | 1,064.35 Cr | 1,822.1948 Cr | 683.29 Cr | 649.46 Cr | 355.24 Cr | 1,491.38 Cr | 25.02 Cr | 19.27 Cr | 0.00 Cr | 611.5362 Cr |
| 2021-03-31 | 122.85 Cr | 2,632.37 Cr | 1,164.87 Cr | 1,478.6666 Cr | 845.93 Cr | 723.09 Cr | 316.84 Cr | 1,330.82 Cr | 7.48 Cr | 17.80 Cr | 0.00 Cr | 603.5029 Cr |
| 2020-03-31 | 44.31 Cr | 1,989.20 Cr | 667.75 Cr | 1,329.3627 Cr | 391.98 Cr | 347.66 Cr | 226.43 Cr | 1,091.33 Cr | 3.98 Cr | 21.67 Cr | 10.45 Cr | 410.8158 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 44.3534 Cr | -166.5844 Cr | 139.1440 Cr | -49.2221 Cr | 11.3540 Cr | 30.4254 Cr | -184.5605 Cr | 31.8742 Cr | 139.6718 Cr | 0.0000 Cr | -25.1071 Cr |
| 2023-03-31 | 179.9236 Cr | -232.6122 Cr | 45.7981 Cr | -46.7438 Cr | -6.5509 Cr | 19.0714 Cr | -226.6674 Cr | -38.2795 Cr | -27.9970 Cr | -9.5482 Cr | 35.4173 Cr |
| 2022-03-31 | 105.1333 Cr | -285.4984 Cr | 82.8583 Cr | -226.6928 Cr | -97.5067 Cr | 25.3391 Cr | -331.8261 Cr | 102.2648 Cr | -163.0498 Cr | -8.9680 Cr | -38.4010 Cr |
| 2021-03-31 | 46.9278 Cr | -404.2761 Cr | 436.3741 Cr | -307.3143 Cr | 79.0259 Cr | 123.3402 Cr | -354.2421 Cr | 195.0519 Cr | 458.6544 Cr | 0.0000 Cr | -106.3432 Cr |
| 2020-03-31 | 124.3782 Cr | -289.5179 Cr | 175.5024 Cr | -224.9015 Cr | 10.1840 Cr | 44.5628 Cr | -349.2797 Cr | 188.0523 Cr | 193.5900 Cr | -20.6398 Cr | -41.1607 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 319.32 Cr | 91.00 Cr | 228.31 Cr | 0.7150 | 51.88 Cr | 31.78 Cr | 3.25 | 82.17 Cr | 0.0995 |
| 2024-09-30 | 343.80 Cr | 121.98 Cr | 221.82 Cr | 0.6452 | 57.72 Cr | 17.94 Cr | 1.83 | 90.61 Cr | 0.0522 |
| 2024-06-30 | 292.51 Cr | 192.06 Cr | 100.46 Cr | 0.3434 | 46.49 Cr | 14.06 Cr | 1.46 | 79.52 Cr | 0.0481 |
| 2024-03-31 | 291.20 Cr | 190.16 Cr | 101.04 Cr | 0.3470 | 43.43 Cr | 24.50 Cr | 2.82 | 78.68 Cr | 0.0841 |
| 2023-12-31 | 286.48 Cr | 96.52 Cr | 189.96 Cr | 0.6631 | 40.38 Cr | 4.58 Cr | 0.53 | 67.10 Cr | 0.0160 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 17.01 Cr | 19.51 Cr | 36.52 Cr | 0.00 Cr | 326.55 Cr | 859.04 Cr | 1,623.37 Cr | 3,117.33 Cr | 798.14 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 30.44 Cr | 0.00 Cr | 0.00 Cr | 30.44 Cr | 0.00 Cr | 0.00 Cr | -1,799.96 Cr |
| 2024-03-31 | 30.23 Cr | 0.00 Cr | 30.23 Cr | 392.05 Cr | 344.93 Cr | 876.83 Cr | 1,596.19 Cr | 3,093.20 Cr | 1,293.25 Cr |
| 2023-12-31 | -23.98 Cr | 47.96 Cr | 23.98 Cr | 0.00 Cr | 0.00 Cr | 23.98 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 23.73 Cr | 7.48 Cr | 31.21 Cr | 355.39 Cr | 331.60 Cr | 825.12 Cr | 1,549.05 Cr | 3,004.03 Cr | 1,229.44 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 14.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 24.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 4.58 Cr | 53.42 Cr | 0.00 Cr | 0.00 Cr | 53.42 Cr | 77.40 Cr | 23.98 Cr | 0.00 Cr | 53.42 Cr |
| 2023-09-30 | 1.61 Cr | 55.58 Cr | 0.00 Cr | 0.00 Cr | 55.58 Cr | 23.98 Cr | 0.00 Cr | 0.00 Cr | 55.58 Cr |
| 2023-06-30 | 1.18 Cr | 53.49 Cr | 0.00 Cr | 0.00 Cr | 53.49 Cr | 75.06 Cr | 21.56 Cr | 0.00 Cr | 53.49 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2015-11-06 | November 06, 15 | 2:1 |
| 2013-07-16 | July 16, 13 | 3:2 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,744.90 | ₹4,186,497,390,360.00 | ₹1,539,404.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹5,891.50 | ₹1,564,008,080,155.00 | ₹717,304.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,254.60 | ₹1,101,504,496,478.00 | ₹168,941.00 |
| Mankind Pharma Limited | MANKIND | ₹2,588.40 | ₹1,067,918,241,168.00 | ₹342,053.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,177.40 | ₹980,907,622,968.00 | ₹1,938,682.00 |
| Lupin Limited | LUPIN | ₹2,009.20 | ₹917,330,458,276.00 | ₹966,589.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹845.35 | ₹850,616,530,500.00 | ₹1,860,605.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,201.20 | ₹697,658,929,968.00 | ₹653,310.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,000.40 | ₹597,872,826,000.00 | ₹97,948.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,368.80 | ₹386,259,126,032.00 | ₹2,163,260.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,423.80 | ₹361,224,068,436.00 | ₹163,712.00 |
| Laurus Labs Limited | LAURUSLABS | ₹640.35 | ₹345,310,338,375.00 | ₹1,671,228.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,679.20 | ₹334,664,498,320.00 | ₹44,703.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,202.20 | ₹306,037,994,912.00 | ₹330,131.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,658.70 | ₹258,221,804,814.00 | ₹100,079.00 |
| Piramal Enterprises Limited | PEL | ₹1,039.85 | ₹234,462,986,345.00 | ₹552,041.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,401.40 | ₹227,698,028,558.00 | ₹264,593.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,727.50 | ₹218,187,500,000.00 | ₹13,476.00 |
| Eris Lifesciences Limited | ERIS | ₹1,382.90 | ₹188,299,218,053.00 | ₹81,150.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,136.00 | ₹168,533,566,400.00 | ₹53,273.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹849.65 | ₹167,009,863,405.00 | ₹223,768.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹829.80 | ₹148,625,361,828.00 | ₹383,129.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹915.95 | ₹145,893,560,183.00 | ₹228,298.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,906.70 | ₹144,931,500,763.00 | ₹146,966.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹480.20 | ₹116,469,494,344.00 | ₹1,207,487.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,223.50 | ₹86,706,866,654.00 | ₹3,571.00 |
| FDC Limited | FDC | ₹430.60 | ₹70,106,024,754.00 | ₹67,489.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹712.85 | ₹64,608,888,867.00 | ₹374,808.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹658.10 | ₹64,356,197,871.00 | ₹163,074.00 |
| Strides Pharma Science Limited | STAR | ₹640.75 | ₹59,053,256,433.00 | ₹243,236.00 |
| Innova Captab Limited | INNOVACAP | ₹915.85 | ₹52,409,452,141.00 | ₹37,786.00 |
| Hikal Limited | HIKAL | ₹423.80 | ₹52,254,857,850.00 | ₹371,223.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹152.84 | ₹49,599,942,480.00 | ₹505,473.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹633.90 | ₹44,630,236,620.00 | ₹75,809.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹799.75 | ₹40,562,604,224.00 | ₹101,985.00 |
| Sequent Scientific Limited | SEQUENT | ₹148.17 | ₹37,087,247,340.00 | ₹527,793.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,179.20 | ₹36,041,821,488.00 | ₹10,217.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹349.90 | ₹35,087,098,650.00 | ₹40,163.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹361.65 | ₹33,007,795,500.00 | ₹101,872.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹53.91 | ₹29,540,183,967.00 | ₹4,747,370.00 |
| Suven Life Sciences Limited | SUVEN | ₹127.13 | ₹27,723,712,024.00 | ₹173,057.00 |
| Alembic Limited | ALEMBICLTD | ₹105.35 | ₹27,051,965,791.00 | ₹436,085.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹520.70 | ₹25,021,207,514.00 | ₹37,558.00 |
Key Executives
Senior Vice President Domestic Formulations and Biologics
Mr. Rajeev Saxena
Gender: male
Year Born: 1973
Vice President
Mr. Awez Mohinuddin Pathan
Gender: male
Year Born: 1970
Senior Vice President of Technical
Pramod Kumar
Gender: Not Specified
Year Born: 1963
Company Secretary & Compliance Officer
Ms. Ritu Tiwary
Gender: female
Year Born: 1977
Vice President of Projects & Operations and Whole-Time Director
Mr. Sharath Reddy Kalakota M.Pharma
Gender: male
Year Born: 1967
Senior Vice President of Formulation
Mr. Abhay Sapre
Gender: male
Year Born: 1971
Chief Financial Officer
Mr. Alpesh Maheshkumar Dalal
Gender: male
Year Born: 1976
Executive Vice President Formulations for Small Molecules
Ms. Smita Holey
Gender: female
Year Born:
MD & Director
Mr. Vishnukanth Chaturbhuj Bhutada B. Pharm
Gender: male
Year Born: 1962
Chief Operating Officer of Formulations
Dr. Jayant Karajgi
Gender: Not Specified
Year Born: 1967
FAQs about Shilpa Medicare Limited
Who is the CEO of the company?
The CEO is Mr. Vishnukanth Chaturbhuj Bhutada B. Pharm.
What is the current market price of the stock?
The current price is ₹658.10.
What is the 52-week price range?
The range is ₹417.6-959.5.
What is the market capitalization of the company?
The market capitalization is ₹6,435.62 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 72.90.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Shilpa Medicare Limited (ISIN: INE790G01031) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹6,435.62 crores and an average daily volume of 285,202 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.